Source: Marketing Authorisation Holder Revision Year: 2022 Publisher: Oethmaan Biosims (Ply) Ltd, 14 Komatie Road, Emmarentia, Johannesburg, 2195
Sensahist.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, capsule shaped film-coated tablets with break line on one side and “M,” embossed on the other side. |
Each film-coated tablet contains 10 mg cetirizine dihydrochloride.
Contains sugar: Lactose monohydrate.
| Active Ingredient | Description | |
|---|---|---|
| Cetirizine |
Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors. |
| List of Excipients |
|---|
|
Anhydrous calcium hydrogen phosphate, colloidal anhydrous silica, magnesium stearate, maize starch, povidone (K-30), sodium starch glycolate and coating ingredients (hypromellose (E-5), titanium dioxide, propylene glycol and purified talc). |
Packaged in transparent PVC film and aluminium foil blister strips of 10 tablets. Strips are packed per unit carton to market as 10’s or 30’s.
Not all pack sizes are marketed at any one time.
Oethmaan Biosims (Ply) Ltd, 14 Komatie Road, Emmarentia, Johannesburg, 2195
42/5.7.1/0822
Date of registration: 20 June 2013
| Drug | Countries | |
|---|---|---|
| SENSAHIST | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
